arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

ANGIODYNAMICS INC

ANGO
$11.82 ▼ -0.43 (-3.51%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

ANGIODYNAMICS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $490.8M
Dividend Yield —
Revenue Growth 9.5% ↗
Op. Margin -12.5% ↗
ROIC -23.7% ↘
FCF / Share $0.01 ↗
Trailing P/E —
Price / Book 2.9x
FCF Yield 0.1%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$320.17M
↑ +9.5% —
Net Income Profit after all expenses
$-36.74M
↓ -8.1% —
Operating Margin Operating profit as % of sales
-12.5%
↑ +8.7% 9th
FCF / Share Free cash flow per share
$0.01
↑ +103.4% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
13
Returns ↓
24
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 67 quarters